Back to Search
Start Over
A dominant activating RAC2 variant associated with immunodeficiency and pulmonary disease
- Source :
- Smits, B M, Lelieveld, P H C, Ververs, F A, Turkenburg, M, de Koning, C, van Dijk, M, Leavis, H L, Boelens, J J, Lindemans, C A, Bloem, A C, van de Corput, L, van Montfrans, J, Nierkens, S, van Gijn, M E, Geerke, D P, Waterham, H R, Koenderman, L & Boes, M 2020, ' A dominant activating RAC2 variant associated with immunodeficiency and pulmonary disease ', Clinical Immunology, vol. 212, 108248, pp. 1-3 . https://doi.org/10.1016/j.clim.2019.108248, Clinical Immunology, 212:108248, 1-3. Academic Press Inc., Clinical immunology (Orlando, Fla.), 212:108248. Academic Press Inc.
- Publication Year :
- 2020
- Publisher :
- Academic Press Inc., 2020.
- Subjects :
- Adult
Lung Diseases
Male
Heterozygote
Neutrophils
Primary Immunodeficiency Diseases
T-Lymphocytes
medicine.medical_treatment
Immunology
Graft vs Host Disease
Pulmonary disease
Hematopoietic stem cell transplantation
Bioinformatics
Molecular Docking Simulation
Text mining
Recurrence
T-Lymphocyte Subsets
Lymphopenia
medicine
Humans
Immunology and Allergy
Lung transplantation
Respiratory Tract Infections
Immunodeficiency
B-Lymphocytes
business.industry
GTPase-Activating Proteins
Disease progression
Hematopoietic Stem Cell Transplantation
Infant
Heterozygote advantage
medicine.disease
rac GTP-Binding Proteins
Gain of Function Mutation
Disease Progression
Guanosine Triphosphate
business
Immunologic Memory
Immunosuppressive Agents
Lung Transplantation
Subjects
Details
- Language :
- English
- ISSN :
- 15216616
- Volume :
- 212
- Database :
- OpenAIRE
- Journal :
- Clinical Immunology
- Accession number :
- edsair.doi.dedup.....dcad1ab469c1445b90e287341cffff98
- Full Text :
- https://doi.org/10.1016/j.clim.2019.108248